dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Callejo Perez, Ana |
dc.contributor.author | Iranzo Gómez, Patricia |
dc.contributor.author | Diaz-Mejia, Nely |
dc.contributor.author | Marmolejo Castañeda, David |
dc.contributor.author | Assaf, Juan David |
dc.contributor.author | Cedres Perez, Susana |
dc.contributor.author | Martínez Marti, Alexandre |
dc.contributor.author | Navarro Mendivil, Alejandro |
dc.contributor.author | Pardo Aranda, Nuria |
dc.contributor.author | Amat, Ramon |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Carbonell, Caterina |
dc.contributor.author | Frigola Rissech, Joan |
dc.date.accessioned | 2022-03-22T13:50:16Z |
dc.date.available | 2022-03-22T13:50:16Z |
dc.date.issued | 2021-07 |
dc.identifier.citation | Callejo A, Frigola J, Iranzo P, Carbonell C, Diaz N, Marmolejo D, et al. Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients. Cancers. 2021 Jul;13(13):3249. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/7232 |
dc.description | Biomarcadors; Esdeveniments adversos relacionats amb el sistema immunitari; Immunoteràpia |
dc.description.sponsorship | None associated with this project. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;13(13) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Medicaments antineoplàstics - Ús terapèutic - Eficàcia |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antineoplastic Agents |
dc.subject.mesh | /therapeutic use |
dc.title | Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers13133249 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antineoplásicos |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.3390/cancers13133249 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Callejo A, Iranzo P, Diaz N, Assaf JD, Cedrés S, Martinez-Marti A, Navarro A, Pardo N] Clinical Research Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Frigola J, Carbonell C, Amat R] Thoracic Cancers Translational Genomics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Marmolejo D] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Felip E] Clinical Research Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Thoracic Cancers Translational Genomics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34209601 |
dc.identifier.wos | 000671992400001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |